Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
318 Ergebnisse für "gene" unter Roche Glycart AG
Cell and Gene Therapy
... Conceptualize. Optimize. Standardize. Advancing concepts to commercialization Cell and gene ... cell and gene therapies is a challenge by the diversity of starting materials and processes used. In ... Cell and Gene Therapy ... https://custombiotech.roche.com/home/featured-solutions/cell-and- gene-therapy.html ... Cell and Gene Therapy ...
LightCycler® 480 Instrument II
... for gene detection, gene expression analysis, genetic variation analysis, and array data validation ... , and can be integrated into everyday use as an automated high-throughput solution. Gene Quantification ... -performance, medium-to high-throughput PCR platform that provides various methods for gene detection, gene ... applications Rely on the LightCycler ® 480 System to perform: Gene Quantification Gene detection Absolute ...
Dinaqor
8952 Schlieren, Wagistrasse 25
DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure.
Dinaqor
Wagistrasse 25
8952 Schlieren
131 Ergebnisse für "gene" unter Dinaqor
Gene Therapy Pipeline – DiNAQOR
... Gene Therapy Pipeline Gene Therapy Pipeline We have a deep understanding and experience in ... cardiology and gene therapy and are committed to advancing novel and innovative solutions for adults and ... Gene Therapy Pipeline – DiNAQOR ... https://www.dinaqor.com/ gene-therapy-pipeline/ ... Gene Therapy Pipeline – DiNAQOR ...
Gene/Protein – DiNAQOR
... Gene/Protein We are committed to advancing gene therapy programs for patients affected by monogenic ... cardiomyopathies. The cardiac myosin-binding protein C gene (MYBPC3) carries mutations in up to 40% of monogenic ... Gene/Protein – DiNAQOR ... https://www.dinaqor.com/platform/ gene-protein/ ... Gene/Protein – DiNAQOR ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
3112 Ergebnisse für "gene" unter Somagenetix
UZH - Soziologisches Institut - Gene expression
... Gene expression in the life course New evidence from Add Health Principle investigator: Prof. Dr ... gene expression patterns. With Kathleen Mullan Harris, Mike Shanahan has collected mRNA data from a ... UZH - Soziologisches Institut - Gene expression ... https://www.suz.uzh.ch/de/forschung/lebenslauf_und_generationen/ gene-expression-in-the-life-course ... UZH - Soziologisches Institut - Gene expression ...
UZH - URPP ITINERARE - Myeloid targeted gene therapy
... News Myeloid targeted gene therapy The myeloid compartment of the immune system plays a crucial ... involved in keeping inflammatory processes in check. We develop novel technology for effective gene ... UZH - URPP ITINERARE - Myeloid targeted gene therapy ... https://www.itinerare.uzh.ch/en/Research/ Gene-editing,-Targeting-and-Delivery/Myeloid-targeted- gene ... UZH - URPP ITINERARE - Myeloid targeted gene therapy ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
196 Ergebnisse für "gene" unter ETH Entrepreneurship
Finding Predictive Gene Groups from Microarray Data
... Analysis, that combines gene selection, gene grouping and sample classification in a supervised ... identifies gene groups whose expression centroids have very good predictive potential and yield results ... Finding Predictive Gene Groups from Microarray Data ... Finding Predictive Gene Groups from Microarray Data Finding Predictive Gene Groups from Microarray ... Finding Predictive Gene Groups from Microarray Data ...
A Tissue-aware Gene Selection Approach for Analyzing Multi-tissue G...
... A Tissue-aware Gene Selection Approach for Analyzing Multi-tissue Gene Expression Data 2018 IEEE ... Tissue-aware Gene Selection Approach for Analyzing Multi-tissue Gene Expression Data Cindy Perscheid ... A Tissue-aware Gene Selection Approach for Analyzing Multi-tissue Gene Expression Data ... A Tissue-aware Gene Selection Approach for Analyzing Multi-tissue Gene Expression Data 2018 IEEE ... A Tissue-aware Gene Selection Approach for Analyzing Multi-tissue Gene Expression Data ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
1160 Ergebnisse für "gene" unter University of Zurich
UZH - ImmuGene - Gene Therapy for Severe Immunodeficiency
... Breadcrumb Institute for Regenerative Medicines ImmuGene - Gene Therapy for patients with unmet ... , metabolic system, immune defects and cancer by gene and cell therapies. The group of Prof. Reichenbach at ... UZH - ImmuGene - Gene Therapy for Severe Immunodeficiency ... UZH - ImmuGene - Gene Therapy for Severe Immunodeficiency Home Main navigation Search Jump to ... UZH - ImmuGene - Gene Therapy for Severe Immunodeficiency ...
Gene patentieren. Eine ethische Analyse - Zurich Open Repository an...
... . Insbesondere an der Frage, ob transgene Lebewesen sowie Gene und Gensequenzen patentiert werden dürfen ... moralischer Hinsicht. Insbesondere an der Frage, ob transgene Lebewesen sowie Gene und Gensequenzen patentiert ... Gene patentieren. Eine ethische Analyse - Zurich Open Repository and Archive ... Gene patentieren. Eine ethische Analyse - Zurich Open Repository and Archive Header Quicknavigation ... Gene patentieren. Eine ethische Analyse - Zurich Open Repository and Archive ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
16 Ergebnisse für "gene" unter Bio-Technopark Schlieren-Zürich
DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Comp...
... News DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New ... forward to partnering with the world’s leading gene therapy companies,” said Johannes Holzmeister, M.D ... DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to ... https://www.bio-technopark.ch/en/news-en/dinaqor-opens-dinamiqs-subsidiary-to-partner-with- gene ... DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to ...
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to ...
... -viral Gene Therapies SCHLIEREN, ZURICH, September 16, 2021 — Anjarium Biosciences AG (“Anjarium”), a ... biotech company focused on creating and delivering a new class of non-viral gene therapies today announced ... -financing-to-develop-next-generation-non-viral- gene-therapies/ ... -viral Gene Therapies › BIO-TECHNOPARK® Schlieren-Zürich Show navigation de en Home Events Jobs Contact ...
Dinamiqs – a Siegfried company
8952 Schlieren, Wagistrasse 25
We are a science-driven contract development and manufacturing organization offering end-to-end viral vector manufacturing solutions. We offer customized services for companies and institutions developing innovative genetic medicines. As a science and technology-driven platform, we provide a comprehensive approach to viral vector manufacturing, from lab-scale development to scalable bioreactor implementation, process optimization, formulation, and stringent quality control.
Dinamiqs – a Siegfried company
Wagistrasse 25
8952 Schlieren
20 Ergebnisse für "gene" unter Dinamiqs – a Siegfried company
DINAMIQS to attend Meeting on the Med - DINAMIQS
... DINAMIQS to attend Meeting on the Med Join us in Rome from April 15-17. The 2025 Cell and Gene ... issues facing cell and gene therapy. ... -17. The 2025 Cell and Gene Meeting on the Med is just around the corner, and we’re looking to ... connecting to tackle the most pressing issues facing cell and gene therapy. To top DINAMIQS Wagistrasse 18 ...
We are open for partnerships - DINAMIQS
... solutions can accelerate their gene therapy projects. ... accelerate their gene therapy projects. To top DINAMIQS Wagistrasse 18 8952 Schlieren, Switzerland info ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
173 Ergebnisse für "gene" unter University Hospital Zurich, Research and Education Office
Research group Roberto Speck – USZ
... experimental HIV medicine, in particular immunotherapy and gene engineering an HIV resistant immune system, and ... in gene-engineering monocytes/macrophages to fight cancer. We use all kinds of in vitro and in vivo ... particular immunotherapy and gene engineering an HIV resistant immune system, and in gene-engineering ... gain insight into HIV pathogenesis, the immune network and to advance gene engineering as well as to ...
... EPIGENETICS, GENETICS AND GENOMICS SYSTEMS BIOLOGY OF GENE REGULATION SNF Prof. Dr. Tuncay Baubec ... tuncay.baubec@uzh.ch www.baubeclab.org KEYWORDS – Epigenetics, Gene Regulation, Functional Genomics, Genome ... EPIGENETICS, GENETICS AND GENOMICS SYSTEMS BIOLOGY OF GENE REGULATION SNF Prof. Dr. Tuncay Baubec ... tuncay.baubec@uzh.ch www.baubeclab.org KEYWORDS – Epigenetics, Gene Regulation, Functional Genomics, Genome ...
Zentrum für Kardiovaskuläre Genetik und Gendiagnostik c/o Stiftung für Menschen mit seltenen Krankheiten
8952 Schlieren, Wagistrasse 25
+41 43 433 86 86
sekretariat@genetikzentrum.ch
Das Zentrum für Kardiovaskuläre Genetik und Gendiagnostik ist schweizweit das erste und einzige Zentrum, welches auf die molekulare Gendiagnostik und die Erforschung genetisch bedingter Aortenkrankheiten und deren klinische Konsequenzen, wie Aneurysmen und Dissektionen, spezialisiert ist.
Zentrum für Kardiovaskuläre Genetik und Gendiagnostik c/o Stiftung für Menschen mit seltenen Krankheiten
Wagistrasse 25
8952 Schlieren
9 Ergebnisse für "gene" unter Zentrum für Kardiovaskuläre Genetik und Gendiagnostik c/o Stiftung für Menschen mit seltenen Krankheiten
Zentrum für Kardiovaskuläre Genetik und Gendiagnostik | 8952 Schlie...
... aortic diseases (PhD thesis, UZH). Nguyen T. (2015) Assessment of the role of KLF2 and KLF15 gene ... medicine, UZH). Fischler M. (2013) Assessment of the role of the DCN gene in patients with suspected Marfan ... role of KLF2 and KLF15 gene mutations in patients with suspected Marfan syndrome and related aortic ... disorders (Master thesis in human medicine, UZH). Fischler M. (2013) Assessment of the role of the DCN gene ...
Zentrum für Kardiovaskuläre Genetik und Gendiagnostik | 8952 Schlie...
... research are published in international scientific journals, communicated to students, and applied in gene ... , communicated to students, and applied in gene diagnostics. » Mission statement (pdf) » Selected scientific ...
Molecular Partners AG
http://www.molecularpartners.com
8952 Schlieren, Wagistrasse 14
+41 44 755 77 00
Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.
Molecular Partners AG
Wagistrasse 14
8952 Schlieren
1 Ergebnisse für "gene" unter Molecular Partners AG
Jörn Aldag - Molecular Partners
... Partners AG. He is the CEO of the gene therapy company Nasdaq-listed uniQure N.V., The Netherlands, which ... received the first approval of a gene therapy product by any Western regulatory agency. Prior to uniQure ... Directors > Jörn Aldag Jörn Aldag Jörn Aldag is Chairman of Molecular Partners AG. He is the CEO of the gene ... therapy company Nasdaq-listed uniQure N.V., The Netherlands, which received the first approval of a gene ...